Share

March 17, 2020; 94 (11) Article

Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy

Georgia Zeng, Ross Penninkilampi, Joga Chaganti, Sara Montagnese, Bruce J. Brew, Mark Danta
First published January 9, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008899
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
107

Share

Article Information

vol. 94 no. 11 e1147-e1156
DOI: 
https://doi.org/10.1212/WNL.0000000000008899
PubMed: 
31919113
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 10, 2019
  • Accepted in final form September 20, 2019
  • First Published January 9, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Georgia Zeng,
    2. Ross Penninkilampi,
    3. Joga Chaganti, MBBS, MD,
    4. Sara Montagnese, MD, PhD,
    5. Bruce J. Brew, MBBS, MD, DSc and
    6. Mark Danta, BMed, MPH, MD
  1. Georgia Zeng,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) St Vincent’s Foundation Clinic Grant 2018

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ross Penninkilampi,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Joga Chaganti, MBBS, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Sara Montagnese, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Hepatology (associate editor)Frontiers in Physiology (associate editor)Hepatology (board)BMJ - Gastro (associate editor)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Umecrine consultancyMerz GmB consultancy

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Bruce J. Brew, MBBS, MD, DSc and
    6. Scientific Advisory Boards:

    1. Biogen Idec Viiv Johnson and Johnson

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Biogen Idec speaker honoraria Johnson and Johnson honoraria

    Editorial Boards:

    1. International Journal for Tryptophan Research, member 2008- Faculty of 1000 Medicine member 2008- Journal of Neurovirology, member 2009- Neurobehavioral HIV Medicine, member 2009- AIDS 2017- Lancet HIV 2017-

    Patents:

    1. Monoclonal antibody for Quinolinic acid as part of test kit for monitoring MS severity and progression (PCT/IB2013/055902;

    Publishing Royalties:

    1. Oxford University Press for HIV Neurology Cambridge University Press for Palliative management in neurological disorders: a practical guide.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. GlaxoSmithKline, speaker, 2005-2009 ViiV Healthcare, 2010, 2016 Boehringer Ingelheim, 2005-2010 Abbott, 2009-2010, 2015 Biogen Idec 2006, 2008 Novartis 2017

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Idec

    Research Support, Government Entities:

    1. NIH NHMRC

    Research Support, Academic Entities:

    1. UNSW

    Research Support, Foundations and Societies:

    1. St Vincent's Clinic Research Foundation 2009-2018

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Mark Danta, BMed, MPH, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Excelixis commercial study meeting airfare and hotel Madrigal commercial study meeting airfare and hotel ASHM non-profit speaker honoraria

    Editorial Boards:

    1. Editorial board of Alimentary Pharmacology and Therapeutics since 2014

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Faculty of Medicine (G.Z., B.B., M.D.), St Vincent's Clinical School, UNSW; Departments of Gastroenterology (G.Z., M.D.), Medical Imaging (J.C.), and Neurology and Immunology (B.B.), St Vincent's Hospital; Faculty of Medicine (R.P.), South Western Sydney Clinical School, UNSW, Sydney, Australia; and Department of Medicine (S.M.), University of Padua, Italy.
  1. Correspondence
    Dr. Danta m.danta{at}unsw.edu.au
View Full Text

Article usage

Article usage: January 2020 to April 2022

AbstractFullPdfSource
Jan 2020366023Highwire
Feb 20206301Highwire
Mar 20205453216Highwire
Apr 2020119119Highwire
May 20207344Highwire
Jun 20206911Highwire
Jul 202011121Highwire
Aug 20205331Highwire
Sep 20207166Highwire
Oct 20206852Highwire
Nov 20207461Highwire
Dec 202016763Highwire
Jan 2021112104Highwire
Feb 20218823Highwire
Mar 20216221Highwire
Apr 202110544Highwire
May 20218101Highwire
Jun 20215564Highwire
Jul 20216711Highwire
Aug 202111217Highwire
Sep 20215421Highwire
Oct 20216000Highwire
Nov 20219022Highwire
Dec 20215211Highwire
Jan 20223964Highwire
Feb 20226213Highwire
Mar 20227611Highwire
Apr 20226142Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me